Overview

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
A phase 3 study in the treatment of subjects >or= 60 years old with newly diagnosed acute lymphoblastic leukemia (ALL).
Phase:
Phase 3
Details
Lead Sponsor:
Spectrum Pharmaceuticals, Inc
Treatments:
Vincristine